Impact of pharmacologic therapy for benign prostatic hyperplasia on prostate volume and free testosterone and consequently on urinary parameters and sexual desire in men
Background/Aim. Pharmacologic therapy for benign prostatic hyperplasia (BPH) relieves disease progression and affects the androgen hormone status. A decrease in the level of free testosterone (freeT) within total testosterone (totalT) leads to symptoms of sexual dysfunction. The aim of this study wa...
Saved in:
| Main Authors: | Stojanović Nebojša, Đenić Nebojša, Bogdanović Dragan, Lazarević Konstansa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
2017-01-01
|
| Series: | Vojnosanitetski Pregled |
| Subjects: | |
| Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2017/0042-84501600166S.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of benign prostatic hyperplasia surgical treatment on voiding and urinary bladder filling symptoms
by: Milićević Snježana, et al.
Published: (2010-01-01) -
Immunohistochemical expression of androgen receptors in prostate carcinoma and benign prostatic hyperplasia
by: Trivunić-Dajko Sandra, et al.
Published: (2020-01-01) -
Benign prostatic hyperplasia and prostate-specific antigen
by: Pejčić Tomislav, et al.
Published: (2015-01-01) -
The Relationship between Erectile Dysfunction and Lower Urinary Tract Symptoms in Subjects with Moderate-to-Severe Symptoms as Predictive Signs of Benign Prostatic Hyperplasia
by: Adil Ibraheem, et al.
Published: (2025-01-01) -
DECOMPENSATED URINARY BLADDER DUE TO BENIGN PROSTATIC HYPERPLASIA (LITERATURE REVIEW)
by: O.O. Sherstyuk, et al.
Published: (2022-08-01)